IDEAS home Printed from https://ideas.repec.org/a/spr/pharmo/v8y2024i1d10.1007_s41669-023-00447-6.html
   My bibliography  Save this article

Exploring the Influence of Health Insurance Plans on Biosimilar Adoption Rates

Author

Listed:
  • Jeremy Costin

    (Johns Hopkins Bloomberg School of Public Health)

  • Morgane C. Mouslim

    (University of Maryland, Baltimore County)

  • Mariana P. Socal

    (Johns Hopkins Bloomberg School of Public Health)

  • Antonio Trujillo

    (Johns Hopkins Bloomberg School of Public Health)

Abstract

Background We conducted a study to investigate the role of health insurance plans on biosimilar adoption among commercially insured patients in the USA. Flexible and rigid health plans may exhibit differing biosimilar coverage due to variations in cost considerations, formulary design, and provider networks. Objective To identify the characteristics of switchers and biosimilar initiators for six biologic-biosimilar pairs. Methods Using claims data from 2015 to 2019, we implement sequential regression models to assess the role of health plans on biosimilars adoption. Findings We found that low-flexibility plans, such as Health Maintenance Organization (HMOs) and Exclusive Provider Organization (EPOs), are more likely to have patients who are switchers and/or biosimilar initiators. Conclusion Our findings highlight the importance of health insurance plan design in promoting biosimilar uptake.

Suggested Citation

  • Jeremy Costin & Morgane C. Mouslim & Mariana P. Socal & Antonio Trujillo, 2024. "Exploring the Influence of Health Insurance Plans on Biosimilar Adoption Rates," PharmacoEconomics - Open, Springer, vol. 8(1), pages 115-118, January.
    • Handle: RePEc:spr:pharmo:v:8:y:2024:i:1:d:10.1007_s41669-023-00447-6
    DOI: 10.1007/s41669-023-00447-6
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s41669-023-00447-6
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1007/s41669-023-00447-6?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:pharmo:v:8:y:2024:i:1:d:10.1007_s41669-023-00447-6. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.